Growth Metrics

AC Immune (ACIU) Free Cash Flow (2016 - 2025)

AC Immune has reported Free Cash Flow over the past 10 years, most recently at -$20.8 million for Q4 2025.

  • Quarterly Free Cash Flow fell 402.45% to -$20.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$63.2 million through Mar 2026, down 225.27% year-over-year, with the annual reading at -$87.7 million for FY2025, 215.63% down from the prior year.
  • Free Cash Flow was -$20.8 million for Q4 2025 at AC Immune, up from -$23.3 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $80.8 million in Q2 2024 and troughed at -$24.5 million in Q1 2022.
  • The 5-year median for Free Cash Flow is -$18.1 million (2023), against an average of -$11.5 million.
  • Year-over-year, Free Cash Flow soared 617.89% in 2024 and then crashed 1548.68% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$23.8 million in 2021, then grew by 15.07% to -$20.2 million in 2022, then increased by 9.45% to -$18.3 million in 2023, then skyrocketed by 137.64% to $6.9 million in 2024, then crashed by 402.45% to -$20.8 million in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Free Cash Flow are -$20.8 million (Q4 2025), -$23.3 million (Q3 2025), and -$19.1 million (Q2 2025).